PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy

Author(s):: Kleinovink, J.W.; Marijt, K.A.; Schoonderwoerd, M.J.A.; Hall, T. van (0000-0002-9115-558X); Ossendorp, F.; Fransen, M.F.

Published: 2017
Publication type: Article / Letter to editor

Biomarkercheckpoint blockadeexpressionimmunotherapyPD-L1PD-1

Date issued: 2017-12-31
Language: English
Is part of: OncoImmunology (2017), No. 4
hdl: 1887/117302
doi: 10.1080/2162402X.2017.1294299